Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 01, 2026
Cboe Global Markets (CBOE): Q1 2026 Earnings Preview Amid Record Volumes and +35% EPS Growth

Cboe Global Markets (CBOE): Q1 2026 Earnings Preview Amid Record Volumes and +35% EPS Growth

Key Takeaways

  • Analysts forecast first-quarter 2026 adjusted EPS of $3.37, representing 35% year-over-year growth from $2.50.
  • Consensus revenue estimate stands at $709 million, up 25% from $565 million in Q1 2025.
  • March 2026 trading volumes hit records, including S&P 500 Index (SPX) options average daily volume (ADV) of 5.4 million contracts and SPX zero-days-to-expiry (0DTE) options at 3.2 million.
  • Preliminary revenue per contract (RPC) for Q1 remains stable across options and futures segments.
  • Cboe has beaten EPS estimates in recent quarters, with a 4.4% surprise in Q4 2025.
  • Strong derivatives and equities volumes position the company for potential outperformance amid elevated market volatility.

Earnings Context and Why It Matters

Cboe Global Markets (CBOE), as a leading global exchange operator, draws most of its revenue from trading fees on options, futures, and equities. From what I see, this first-quarter 2026 earnings report stands out because it captures ongoing market volatility and record options activity, especially in SPX and 0DTE products. Investors like me are paying close attention for evidence of lasting volume growth and steady margins, building on the record EPS beat from Q4 2025. With shares hovering near all-time highs, these results could confirm the durability of derivatives strength against geopolitical tensions and economic uncertainty, while underscoring CBOE's market share advances in a competitive field.

Earnings Expectations

Wall Street expects solid growth here, with consensus adjusted EPS pegged at $3.37 alongside $708.61 million in net revenue—marking 35% and 25% gains, respectively, from Q1 2025's $2.50 EPS and $565 million revenue. Recent upward revisions in estimates reflect this optimism, fueled by record quarterly ADV in proprietary index options at 6.1 million contracts. I also checked comparable metrics using Tickeron’s AI Screener to gauge how CBOE stacks up against industry peers.

Key figures to watch include derivatives net revenue, driven by high SPX and VIX volumes, plus data and access fees. Preliminary Q1 RPC/net revenue capture guidance indicates stability: $0.342 for total options and $1.649 for futures. CBOE has a track record of EPS beats, like the Q4 2025 surprise, and the stock has typically reacted positively to surprises over the past five years.

Market Reaction and Investor Sentiment

Sentiment heading into earnings leans bullish, supported by March's volume records and all-time highs in European equities ADNV. Options pricing suggests a potential 5-7% stock move after the report, in line with CBOE's historical patterns. That said, risks linger, such as softer RPC if volatility eases or if regulatory scrutiny on 0DTE trading intensifies. The stock has proven resilient, climbing on 14 of 20 recent earnings days tied to positive surprises.

Tools I Use: Tickeron’s AI Screener

One tool I rely on regularly for this kind of analysis is Tickeron’s AI Screener, an AI-powered stock and ETF discovery platform that lets me filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. It scans thousands of stocks and ETFs with customizable criteria like industry, market cap, technical indicators, price patterns, and performance metrics, surfacing trade ideas, trending names, breakouts, and opportunities far more efficiently than manual methods. This helps me make data-driven calls across different strategies.

Forward Outlook and Key Factors to Monitor

I'll be looking closely at updated full-year 2026 guidance, especially net revenue growth and adjusted EPS projections amid persistent market turbulence. CBOE's focus on proprietary products like SPX and VIX options points to ongoing derivatives momentum, assuming volatility holds.

Net revenue capture rates will be telling—stable RPC with elevated volumes could support stronger margins. Equities transaction volumes, lifted by off-exchange growth, along with international progress in Europe and FX, deserve scrutiny. The earnings call might reveal catalysts such as new product launches or M&A activity.

Macro factors like interest rate trajectories and geopolitical developments that fuel volatility will play a big role. Cost discipline and tech investments should also influence operating efficiency. Keeping an eye on monthly volume reports will offer early clues for Q2.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: CBOE

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CBOE sees MACD Histogram crosses below signal line

CBOE saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 07, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 55 instances where the indicator turned negative. In of the 55 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CBOE moved out of overbought territory on August 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBOE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CBOE broke above its upper Bollinger Band on August 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where CBOE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 20, 2026. You may want to consider a long position or call options on CBOE as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CBOE moved above its 50-day moving average on July 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CBOE crossed bullishly above the 50-day moving average on July 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CBOE advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 270 cases where CBOE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CBOE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.583) is normal, around the industry mean (5.815). P/E Ratio (23.440) is within average values for comparable stocks, (26.690). Projected Growth (PEG Ratio) (2.555) is also within normal values, averaging (3.218). Dividend Yield (0.010) settles around the average of (0.020) among similar stocks. P/S Ratio (6.246) is also within normal values, averaging (8.451).

Notable companies

The most notable companies in this group are CME Group (NASDAQ:CME).

Industry description

The financial publishing /services sector includes companies that provide informational products and services that are of value to investors, financial/analytics professionals and other interested readers. The products include real-time stock quotes, financial news and analyses. Think S&P Global, Inc., Moody`s Corporation, Thomson-Reuters Corp and IHS Markit Ltd. Information is critical in making financial or investment decisions, and what makes this industry’s output relevant at all times, across various economic conditions.

Market Cap

The average market capitalization across the Financial Publishing/Services Industry is 41.05B. The market cap for tickers in the group ranges from 3.1M to 127.14B. SPGI holds the highest valuation in this group at 127.14B. The lowest valued company is BTOG at 3.1M.

High and low price notable news

The average weekly price growth across all stocks in the Financial Publishing/Services Industry was 29%. For the same Industry, the average monthly price growth was 30%, and the average quarterly price growth was 19%. DTCX experienced the highest price growth at 35%, while BTOG experienced the biggest fall at -82%.

Volume

The average weekly volume growth across all stocks in the Financial Publishing/Services Industry was 97%. For the same stocks of the Industry, the average monthly volume growth was 42% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 73
Price Growth Rating: 49
SMR Rating: 55
Profit Risk Rating: 79
Seasonality Score: -34 (-100 ... +100)
View a ticker or compare two or three
CBOE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of a marketplace for trading equity and index options

Industry FinancialPublishingServices

Profile
Details
Industry
Investment Banks Or Brokers
Address
433 West Van Buren Street
Phone
+1 312 786-5600
Employees
1685
Web
https://www.cboe.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
Cboe Global Markets (CBOE): Q1 2026 Earnings Preview Amid Record Volumes and +35% EPS Growth